@FierceBiotech: Feature: Top 10 Biotech CEO Pay Packages of 2012. Special Report | Follow @FierceBiotech
@JohnCFierce: A "rational" market finally develops an appetite for biotech IPOs. Story | Follow @JohnCFierce
@RyanMFierce: Cash-strapped biotech Seaside Tx fails PhIII test for pioneering Fragile X drug. More | Follow @RyanMFierce
> BioMarin ($BMRN) shares surged yesterday as analysts whetted investors' appetite for its upcoming review of its PARP inhibitor BMN-673 at ASCO. Story
> Biogen Idec ($BIIB) formally named Spyros Artavanis-Tsakonas as the company's chief scientific officer. Dr. Artavanis-Tsakonas had served as interim CSO while on sabbatical from Harvard Medical School. Release
> Shares of Oncolytics Biotech ($ONCY) jumped on positive preliminary data for its mid-stage melanoma trial of Reolysin. Story
> Burlingame, CA-based Apexigen, a spinoff of Epitomics, has raised $15 million, according to a filing with the SEC. MedCity News reports that the biotech is using monoclonal antibody tech to discover new cancer drugs. Story
> Celgene ($CELG) says the FDA is approving priority review status for its sNDA on Abraxane for pancreatic cancer. Release
@FierceMedDev: Stryker, OrthoSensor renew knee replacement co-marketing agreement. More | Follow @FierceMedDev
@MarkHFierce: 2013 nominations for the FMD Fierce 15 have begun. More | Follow @MarkHFierce
@DamianFierce: The year is young, but med tech companies are already slashing thousands of jobs. Here's a look at the deepest cuts. Report | Follow @DamianFierce
> Eli Lilly, Corgenix ink cancer drug companion Dx deal. Article
> Boston Scientific's strong results fuel hope for renal denervation success. Story
Pharma News
@FiercePharma: Forest Labs' Howard Solomon to retire from CEO job after 37 years up top, the last few rather stormy. More | Follow @FiercePharma
@EricPFierce: GlaxoSmithKline says Aussie strong dollar, wages lead to 120 job cuts at packing plant in Australia. Article | Follow @EricPFierce
> Merck, Lilly, Pfizer share top billing in $1B doc-payments list. Story
> Forest Labs CEO to step aside at year's end after decades at the helm. News
> Daiichi accuses Ranbaxy shareholders of hiding info before buyout. Article
Pharma Manufacturing News
> J&J consumer healthcare faces more issues, this time in Brazil. Item
> Glaxo packs up a tablet packaging line in Australia. More
> FDA cites Boehringer Ingelheim plant in Germany. Article
> Malaysia's Pharmaniaga slates drug plant in Saudi Arabia. Story
Vaccines News
> Sanofi edges closer to universal flu vaccine. More
> Pfizer points to pandemic potential of Prevnar 13. Item
> Inertia at Pakistan's NIH threatening vaccine programs. Article
> Old whooping cough vax linked with better protection. Story
> Analyst taps Bristol, Roche cancer immunotherapies for explosive growth. News
And Finally… A lethal, SARS-like coronavirus has killed another person in Saudi Arabia, bringing the death toll to 17. Story